Morgan Stanley Cuts Chemours (NYSE:CC) Price Target to $28.00

Chemours (NYSE:CC – Get Free Report) had its price objective lowered by equities researchers at Morgan Stanley from $33.00 to $28.00 in a note issued to investors on Monday, Benzinga reports. The brokerage currently has an “equal weight” rating on the specialty chemicals company’s stock. Morgan Stanley’s target price would indicate a potential upside of […]

Related Keywords

United States ,Canada ,America ,Asia Pacific ,Barclays ,Points Wealth Management ,Ethic Inc ,Chemours Company ,Chemours Company Profile ,Morgan Stanley ,Crescent Grove Advisors ,Specialized Solutions ,Royal Bank ,Get Free Report ,Grove Advisors ,North America ,Middle East ,Titanium Technologies ,Advanced Performance ,Chemours Daily ,Chemours ,Nyse Cc ,Dcc ,Basic Material ,Lower Price Target ,